TMIST (Tomosynthesis Mammographic Imaging Screening Trial)

TMIST is a randomized breast screening trial that compares two Food and Drug Administration (FDA)-approved types of digital mammography, standard digital mammography (2-D) with a newer technology called tomosynthesis mammography (3-D).

from Cancer Information - TMIST (Tomosynthesis Mammographic Imaging Screening Trial)